Working… Menu

BCG With or Without Gefitinib in Treating Patients With High-Risk Bladder Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00352079
Recruitment Status : Terminated (terminated due to poor accrual)
First Posted : July 14, 2006
Last Update Posted : April 3, 2020
Information provided by (Responsible Party):
Canadian Cancer Trials Group ( NCIC Clinical Trials Group )

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : January 6, 2012
Actual Study Completion Date : January 6, 2012